Early Phase Cancer Immunotherapy

Lieferzeit: Lieferbar innerhalb 14 Tagen

160,49 

Current Cancer Research

ISBN: 3319637568
ISBN 13: 9783319637563
Herausgeber: Sandip Pravin Patel/Razelle Kurzrock
Verlag: Springer Verlag GmbH
Umfang: xi, 331 S., 9 s/w Illustr., 15 farbige Illustr., 331 p. 24 illus., 15 illus. in color.
Erscheinungsdatum: 10.11.2017
Auflage: 1/2018
Produktform: Gebunden/Hardback
Einband: Gebunden

This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.

Artikelnummer: 2500020 Kategorie:

Beschreibung

Autorenporträt

Razelle Kurzrock, MD, is Senior Deputy Director for Clinical Science, Chief, Division of Hematology & Oncology, Murray Professor of Medicine, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California, San Diego. Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.

Herstellerkennzeichnung:


Springer Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

E-Mail: juergen.hartmann@springer.com

Das könnte Ihnen auch gefallen …